Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 349 clinical trials
Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients with Light Chain Amyloidosis using Positron Emission Tomography (PET/CT)

This will be followed by a skull base to thigh scan. Florbetaben imaging sessions will include an injection of approximately 8.1 mCi (approximate range for most studies is anticipated to be 6.4 9.7 mCi) of Florbetaben.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Evaluation of Corneal Confocal Microscopy in Ocular Surface Disease and/or Neuropathic Pain Patients

If confocal images have previously been taken for the patient, we would ask for their permission to include those images as well. The populations to be studied for this study will be patients that are 18 years or older and have been diagnosed with ocular surface disease, such as dry …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Prospective Randomized Double-Blind Placebo-Controlled Crossover Study to Evaluate the Clinical Utility of the Vascular Health Profile Diagnostics Assay (VHP) in Assessment of Response to Administration of a HMG-CoA reductase inhibitor (statin) as Primary Prevention in Patients with Asymptomatic Atherosclerosis

Thus, during the second treatment period the treatments will be swapped. Patients and clinical researchers will be blinded with regard to treatment. All subjects who meet the eligibility criteria at the Screening Visit and sign the informed consent form will undergo the study-related procedures.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Integrated biomarker PET/CT imaging trial for assessing hypoxia in soft tissue sarcomas using a novel PET/CT tracer

Subjects will undergo biopsy as part of their clinical care. Subjects will be asked to consent to allow archived excess tissue to be accessed for the purposes of this study to perform experimental histological assays, if enough tissue is available.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Profiling and Perturbing the Human Immune System to Understand the Human Immune Network

This study aims to compare IBD patients with healthy controls to obtain a systems-level view of immune system perturbation by IBD. This intervention (anti-TNF therapy) will be intended to treat IBD but will also represent a major, broad immune system perturbation. Although the response of the patient in terms of …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Development and Maintenance of Software for MR Spectroscopic Imaging

The protocol consists of one or two MRI sessions. Each MRI session will be performed approximately 90 minutes or less. Participants will not be imaged more than one session per day.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A randomized double-blind placebo-controlled parallel group study to evaluate the efficacy and safety of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimers Disease (AD)

Cognitively unimpaired subjects defined as having a Mini-Mental State Examination (MMSE) total score greater than or equal to 24. Subjects must be willing to have a study partner throughout the study. Approximately 2000 participants will be randomized in approximately 135 centers worldwide.

  • 0 views
  • 19 Feb, 2024
  • 1 location
FES PET/CT in Endocrine Refractory Breast Cancer

Patients with recurrent or metastatic ER+ breast cancer, who have failed prior endocrine therapy may be eligible for this study.  Patients may participate in this study, if they are at least 18 years of age, most participants will be receiving care at the clinical practices of the University of Pennsylvania.

  • 0 views
  • 19 Feb, 2024
  • 2 locations
“Real World” Administration of Zepatier (Grazoprevir plus Elbasvir in Chronic Hemodialysis Patients with Hepatitis C Infection. Strategies for Identification of Candidate Hemodialysis Patients, Obtainment of Insurance Approval, Treatment Guidelines, and Laboratory and Clinical Monitoring During Therapy Directed to Nephrologists

If you choose to participate in this study, other testing will be done to see if you qualify. If you do qualify, you will be provided medication for treatment of your hepatitis C at no cost.

  • 0 views
  • 19 Feb, 2024
18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimers Disease

Randomization will occur across 2 clinical subgroups (MCI due to AD/prodromal AD or mild AD dementia), and will be reasonably balanced, such that not less than approximately 50% of total number of subjects will be in the MCI due to AD clinical subgroup.

  • 0 views
  • 19 Feb, 2024
  • 1 location